Skip to content

Author

David Beniameen

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Cancer Nanomedicine: Preclinical Advantages, Translational Bottlenecks, and Future Strategies

This manuscript reviews the current landscape of cancer nanomedicine by comprehensively synthesizing findings from peer-reviewed literature across a number of academic databases, and underscores critical gaps in clinical translation.

David Beniameen, Ahmed Abdelghany · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.